Cargando…
Astrocytes in the Neuropathology of Bipolar Disorder: Review of Current Evidence
(1) Background: Approximately one-third of patients with bipolar disorder (BD) do not experience sustained remission with current treatments. Presently, astrocytes, i.e., glial cells that act as key regulators of neuroinflammation, have been a target for therapeutic development. Research regarding t...
Autores principales: | Dai, Nasia, Jones, Brett D. M., Husain, Muhammad Ishrat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688542/ https://www.ncbi.nlm.nih.gov/pubmed/36358439 http://dx.doi.org/10.3390/brainsci12111513 |
Ejemplares similares
-
Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence
por: Jones, Brett D. M., et al.
Publicado: (2021) -
Systematic review of structured care pathways in major depressive disorder and bipolar disorder
por: Kim, Helena Kyunghee, et al.
Publicado: (2023) -
The neuropathology of bipolar disorder: systematic review and meta-analysis
por: Harrison, Paul J., et al.
Publicado: (2018) -
Roles of neuropathology-associated reactive astrocytes: a systematic review
por: Lawrence, Jill M., et al.
Publicado: (2023) -
COVID-19: Implications for bipolar disorder clinical care and research
por: Xue, Siqi, et al.
Publicado: (2020)